Observational Study of Conception/Pregnancy in Adult Patients With Chronic Myeloid Leukemia (CML) Treated With Tyrosine Kinase Inhibitors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dasatinib; Imatinib; Nilotinib; Protein tyrosine kinase inhibitors
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 23 Oct 2018 Biomarkers information updated
- 11 Sep 2013 Planned end date changed from 1 Jul 2018 to 1 May 2016 as reported by ClinicalTrials.gov.
- 27 Aug 2013 Planned initiation date changed from 1 Jan 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.